Joice Maria da Cunha
Affiliations: | 2000-2004 | Pharmacology | Universidade de São Paulo (Ribeirão Preto, Brazil) |
Google:
"Joice Maria da Cunha"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Sergio Henrique Ferreira | grad student | 2000-2004 | Universidade de São Paulo (Ribeirão Preto, Brazil) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Waltrick APF, Radulski DR, de Oliveira KM, et al. (2024) Early evidence of beneficial and protective effects of Protectin DX treatment on behavior responses and type-1 diabetes mellitus related-parameters: A non-clinical approach. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 133: 111028 |
| Leão FF, Waltrick APF, Verri WA, et al. (2022) Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model. Naunyn-Schmiedeberg's Archives of Pharmacology. 395: 1269-1282 |
| Gasparin AT, Rosa ES, Jesus CHA, et al. (2021) Bixin attenuates mechanical allodynia, anxious and depressive-like behaviors associated with experimental diabetes counteracting oxidative stress and glycated hemoglobin. Brain Research. 1767: 147557 |
| Chaves YC, Genaro K, Crippa JA, et al. (2021) Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease |
| Gonçalves MR, da Conceição MS, Jesus CHA, et al. (2020) Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats. Behavioural Pharmacology |
| Godoi MM, Junior HZ, da Cunha JM, et al. (2020) Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception. Pharmacology, Biochemistry, and Behavior. 194: 172938 |
| Chaves YC, Genaro K, Stern CAJ, et al. (2020) Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes. Neuroscience Letters. 135020 |
| Jesus CHA, Redivo DDB, Gasparin AT, et al. (2019) Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors. Brain Research |
| de Morais H, Chaves YC, Waltrick APF, et al. (2018) Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats. Neuroscience Letters |
| Gambeta E, Sestile CC, Fogaça MV, et al. (2017) A serotonergic deficit in the dorsal periaqueductal gray matter may underpin enhanced panic-like behavior in diabetic rats. Behavioural Pharmacology |